{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:18:15Z","timestamp":1791037095290,"version":"4.1.0"},"reference-count":13,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>TAL-1\/SCL activation is a common genetic event in pediatric T-cell acute lymphoblastic leukemia (T-ALL). Expression of tal-1\/scl or a DNA binding mutant of tal-1\/scl induces arrest of thymocyte development, resulting in decreases in double-positive and single-positive CD4 thymocytes. Moreover, nuclear p65\/p50 heterodimers are detected in premalignant tal-1\/scl and mut tal-1\/scl thymocytes, suggesting that E2A depletion may induce developmental arrest and stimulate NF-\u03baB activation. Increased NF-\u03baB activity is also observed in tal-1\/scl tumors and bcl-2 is overexpressed. To examine the contribution of NF-\u03baB to tal-1\/scl tumor growth in vivo, we expressed a mutant form of I\u03baB\u03b1 in tal-1\/scl tumor cells. Although expression of mutant I\u03baB\u03b1 inhibited the tumor necrosis factor alpha (TNF-\u03b1)-induced NF-\u03baB response, it had no effect on tumor growth in mice. These data suggest that NF-\u03baB activation is an early event in tal-1\/scl-induced leukemogenesis, associated with arrest of thymocyte development, and does not appear to contribute to tal-1\/scl-induced tumor growth. (Blood. 2003;102:2593-2596)<\/jats:p>","DOI":"10.1182\/blood-2003-01-0090","type":"journal-article","created":{"date-parts":[[2003,6,24]],"date-time":"2003-06-24T00:32:50Z","timestamp":1056414770000},"page":"2593-2596","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":12,"title":["NF-\u03baB activation in premalignant mouse tal-1\/scl thymocytes and tumors"],"prefix":"10.1182","volume":"102","author":[{"given":"Jennifer","family":"O'Neil","sequence":"first","affiliation":[{"name":"From the Department of Cancer Biology and the Interdisciplinary Graduate Program, Program in Molecular Medicine, University of Massachusetts Medical School, Worcester."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Jose","family":"Ventura","sequence":"additional","affiliation":[{"name":"From the Department of Cancer Biology and the Interdisciplinary Graduate Program, Program in Molecular Medicine, University of Massachusetts Medical School, Worcester."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Cusson","sequence":"additional","affiliation":[{"name":"From the Department of Cancer Biology and the Interdisciplinary Graduate Program, Program in Molecular Medicine, University of Massachusetts Medical School, Worcester."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Kelliher","sequence":"additional","affiliation":[{"name":"From the Department of Cancer Biology and the Interdisciplinary Graduate Program, Program in Molecular Medicine, University of Massachusetts Medical School, Worcester."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021221445095400_REF1","doi-asserted-by":"crossref","unstructured":"Rayet B, Gelinas C. Aberrant rel\/nfkb genes and activity in human cancer. Oncogene. 1999;18: 6938-6947.","DOI":"10.1038\/sj.onc.1203221"},{"key":"2020021221445095400_REF2","doi-asserted-by":"crossref","unstructured":"Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2: 301-310.","DOI":"10.1038\/nrc780"},{"key":"2020021221445095400_REF3","doi-asserted-by":"crossref","unstructured":"Kordes U, Krappmann D, Heissmeyer V, Ludwig WD, Scheidereit C. Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia. 2000;14: 399-402.","DOI":"10.1038\/sj.leu.2401705"},{"key":"2020021221445095400_REF4","doi-asserted-by":"crossref","unstructured":"Begley CG, Green AR. The SCL gene: from case report to critical hematopoietic regulator. Blood. 1999;93: 2760-2770.","DOI":"10.1182\/blood.V93.9.2760"},{"key":"2020021221445095400_REF5","doi-asserted-by":"crossref","unstructured":"Kelliher MA, Seldin DC, Leder P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J. 1996;15: 5160-5166.","DOI":"10.1002\/j.1460-2075.1996.tb00900.x"},{"key":"2020021221445095400_REF6","doi-asserted-by":"crossref","unstructured":"O'Neil J, Billa M, Oikemus S, Kelliher M. The DNA binding activity of TAL-1 is not required to induce leukemia\/lymphoma in mice. Oncogene. 2001;20: 3897-3905.","DOI":"10.1038\/sj.onc.1204519"},{"key":"2020021221445095400_REF7","doi-asserted-by":"crossref","unstructured":"Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1: 75-87.","DOI":"10.1016\/S1535-6108(02)00018-1"},{"key":"2020021221445095400_REF8","doi-asserted-by":"crossref","unstructured":"Mudgett JS, Ding J, Guh-Siesel L, et al. Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci U S A. 2000;97: 10454-10459.","DOI":"10.1073\/pnas.180316397"},{"key":"2020021221445095400_REF9","doi-asserted-by":"crossref","unstructured":"Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C. The prosurvival Bcl-2 homolog Bfl-1\/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 1999;13: 382-387.","DOI":"10.1101\/gad.13.4.382"},{"key":"2020021221445095400_REF10","doi-asserted-by":"crossref","unstructured":"Grumont RJ, Rourke IJ, Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 1999;13: 400-411.","DOI":"10.1101\/gad.13.4.400"},{"key":"2020021221445095400_REF11","doi-asserted-by":"crossref","unstructured":"Chen C, Edelstein LC, Gelinas C. The Rel\/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol. 2000;20: 2687-2695.","DOI":"10.1128\/MCB.20.8.2687-2695.2000"},{"key":"2020021221445095400_REF12","doi-asserted-by":"crossref","unstructured":"Voll RE, Jimi E, Phillips RJ, et al. NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity. 2000;13: 677-689.","DOI":"10.1016\/S1074-7613(00)00067-4"},{"key":"2020021221445095400_REF13","doi-asserted-by":"crossref","unstructured":"Kim D, Xu M, Nie L, et al. Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel\/NF\u03baB activities. Immunity. 2002;16: 9-21.","DOI":"10.1016\/S1074-7613(02)00264-9"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/7\/2593\/1691734\/h81903002593.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/7\/2593\/1691734\/h81903002593.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T02:50:24Z","timestamp":1581562224000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/102\/7\/2593\/17994\/NF%CE%BAB-activation-in-premalignant-mouse-tal1scl"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,1]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-01-0090","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,1]]}}}